{
    "organizations": [],
    "uuid": "5ad12d486e02c516cf2619010505a470b28c5177",
    "author": "",
    "url": "https://www.reuters.com/article/brief-vanda-pharmaceuticals-wins-appeal/brief-vanda-pharmaceuticals-wins-appeal-case-on-fanapt-idUSFWN1RQ0LE",
    "ord_in_thread": 0,
    "title": "BRIEF-Vanda Pharmaceuticals Wins Appeal Case On Fanapt",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 13, 2018 / 4:06 PM / Updated 38 minutes ago BRIEF-Vanda Pharmaceuticals Wins Appeal Case On Fanapt Reuters Staff \nApril 13 (Reuters) - Vanda Pharmaceuticals Inc : * VANDA WINS APPEAL CASE ON FANAPT® \n* U.S. FEDERAL COURT AFFIRMED U.S. COURT’S DECISION THAT WEST WARD PHARMACEUTICALS INFRINGED CO’S U.S. ‘610 PATENT FOR FANAPT \n* ‘610 PATENT IS SET TO EXPIRE NOVEMBER 2, 2027 Source text for Eikon: Further company coverage:",
    "published": "2018-04-13T19:02:00.000+03:00",
    "crawled": "2018-04-13T19:21:25.032+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "win",
        "appeal",
        "case",
        "fanapt",
        "reuters",
        "staff",
        "april",
        "reuters",
        "vanda",
        "pharmaceutical",
        "inc",
        "vanda",
        "win",
        "appeal",
        "case",
        "federal",
        "court",
        "affirmed",
        "court",
        "decision",
        "west",
        "ward",
        "pharmaceutical",
        "infringed",
        "co",
        "patent",
        "fanapt",
        "patent",
        "set",
        "expire",
        "november",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}